NCT01014767 Intercontinental Multidisciplinary Registry and Treatment Optimization Study for Choroid Plexus Tumors Status TERMINATED Phase PHASE3
NCT01012609 External Beam Radiation Therapy and Cetuximab Followed by Irinotecan and Cetuximab for Children and Young Adults With Newly Diagnosed Diffuse Pontine Tumors and High-Grade Astrocytomas Status COMPLETED Phase PHASE2
NCT00946673 Phase I Vorinostat Concurrent With Stereotactic Radiosurgery (SRS) in Brain Metastases From Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE1
NCT00928226 Study of Fractionated Stereotactic Radiosurgery to Treat Large Brain Metastases Status COMPLETED Phase NA
NCT00883688 Bevacizumab and Lapatinib in Children With Recurrent or Refractory Ependymoma Status COMPLETED Phase PHASE2
NCT00876499 Fatigue, Sleep and Cytokines in Primary Brain Tumor (PBT) Patients Status COMPLETED Phase N/A
NCT00871923 Tarceva With Whole Brain Radiation Therapy - Brain Mets From Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00870129 Magnetic Resonance (MR) Imaging to Determine High Risk Areas in Patients With Malignant Gliomas and to Design Potential Radiation Plans and to Examine Metabolite Changes in Gliomas and Other Solid Tumors Status RECRUITING Phase NA
NCT00832598 [18F] FACBC and [18F] FLT PET Imaging in Central Nervous System Tumors Status COMPLETED Phase NA
NCT00805376 DNX-2401 (Formerly Known as Delta-24-RGD-4C) for Recurrent Malignant Gliomas Status COMPLETED Phase PHASE1
NCT00782756 Bevacizumab, Temozolomide and Hypofractionated Radiotherapy for Patients With Newly Diagnosed Malignant Glioma Status COMPLETED Phase PHASE2
NCT00747253 Monteris AutoLITTâ„¢ FIM Safety Trial for Recurrent/Progressive Brain Tumors Status COMPLETED Phase PHASE1
NCT00723463 Determine if Apparent Diffusion Coefficient (ADC) Values Can Differentiate Tumors From Normal Tissue Status COMPLETED Phase EARLY_PHASE1
NCT00706810 Combination of Hydroxyurea and Verapamil for Refractory Meningiomas Status COMPLETED Phase PHASE2
NCT00636805 Aloxi for Prevention of Chemotherapy Induced Nausea and Vomiting in Malignant Glioma Patients Receiving Irinotecan With Bevacizumab Status TERMINATED Phase PHASE2
NCT00595322 Bevacizumab in the Radiation Treatment of Recurrent Malignant Glioma Status COMPLETED Phase NA